GlassScriptPhysician profile
Dipika S Ambani
NPI 1306957923
$1,156.53
in general payments reported to CMS, 2019-2025
19 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $112 · 2021: $118 · 2022: $98.68 · 2023: $353 · 2024: $164 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581 · Education: $85.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.21 |
| Education | $85.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $178.62 | 2019-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $172.67 | 2021-2025 | Aptima, Thinprep 2000 Processor, Fetal Fibronectin Enzyme Immunoassay |
| Astellas Pharma US INC | $172.30 | 2023-2024 | Veozah |
| Lupin INC. | $81.99 | 2019-2020 | |
| Exeltis, USA INC. | $78.46 | 2019-2024 | Slynd, Tyblume |
| Mayne Pharma Commercial LLC | $56.75 | 2023-2025 | |
| Baxter Healthcare | $51.53 | 2024 | Perclot |
| Abbvie INC. | $51.08 | 2020-2022 | |
| Caldera Medical, INC | $38.68 | 2023 | Desara |
| Shield Therapeutics INC | $36.02 | 2022-2023 | Accrufer |
| Optumhealth Care Solutions, LLC | $35.28 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Novo Nordisk INC | $34.80 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $33.99 | 2019-2022 | |
| Allergan, INC. | $33.90 | 2020 | |
| Gynesonics, INC. | $29.11 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $21.82 | 2024 | Ova1 |
| Organon LLC | $20.03 | 2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $16.85 | 2019 | |
| Scynexis, INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipika Ambani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.